台股 » 智擎 » 個股財報 » 杜邦分析

智擎

(4162)
可現股當沖
  • 股價
    88.9
  • 漲跌
    ▼0.5
  • 漲幅
    -0.56%
  • 成交量
    491
  • 產業
    上櫃 生技醫療類股 ▼0.19%
  • 本地時間:13:30

    309人加入追蹤

    立即追蹤

智擎 (4162) 財務報表-杜邦分析
杜邦分析

稅後淨利率 = 稅後淨利÷營業收入。

總資產週轉率 = (營業收入-營業成本-營業費用)÷營業收入。

權益乘數 = 稅前淨利÷營業收入。

智擎 (4162) ROE-杜邦分析圖

Created with Highstock 1.3.7智擎 (4162)嗨投資 histock.twROE季收盤價2020202020212021202120222022202220232023202320242024202420250%10%20%30%40%255075100125150
Created with Highstock 1.3.7智擎 (4162)嗨投資 histock.tw稅後淨利率總資產週轉率季收盤價2020202020212021202120222022202220232023202320242024202420250%50%100%150%255075100125150
Created with Highstock 1.3.7智擎 (4162)嗨投資 histock.tw權益乘數季收盤價2020202020212021202120222022202220232023202320242024202420250%0.5%1%1.5%255075100125150

智擎 (4162) 歷年杜邦分析

年度/季別ROE稅後淨利率總資產週轉率權益乘數
2024Q430.24%75.49%0.38%1.08
2024Q32.34%42.24%0.05%1.02
2024Q24.06%60.66%0.06%1.08
2024Q12.09%49.69%0.04%1.03
2023Q40.97%19.95%0.05%1.02
2023Q32.13%32.85%0.06%1.02
2023Q21.95%45.23%0.04%1.12
2023Q12.08%48.34%0.04%1.02
2022Q41.39%33.83%0.04%1.02
2022Q32.32%56.47%0.04%1.03
2022Q22.08%48.33%0.04%1.13
2022Q12.43%55.73%0.04%1.02
2021Q42.87%54.72%0.05%1.02
2021Q31.83%41.30%0.04%1.02
2021Q24.01%104.68%0.04%1.03
2021Q11.87%65.45%0.03%1.04
2020Q413.94%66.46%0.20%1.05
2020Q30.53%19.22%0.03%1.04
2020Q20.41%15.95%0.02%1.07
2020Q11.39%58.31%0.02%1.04
〈焦點股〉智擎胰腺癌新藥展望正向 股價帶量衝高Anue鉅亨-2025/03/03
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-2025/02/05
智擎 相關文章